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Constitutive Bcl-2 Expression
during Immunoglobulin Heavy Chain–Promoted B Cell
Differentiation Expands Novel Precursor B Cells
Faith Young,*§ Emiko Mizoguchi,† Atul K. Bhan,† (sIgM1) B cells can migrate from the bone marrow and
colonize peripheral lymphoid organs such as the spleen,and Frederick W. Alt*‡
lymph nodes (LN), and Peyer’s patches. The progression*Howard Hughes Medical Institute
of B-lineage cells through these differentiation stagesand the Department of Genetics and Pediatrics
is accompanied by modulation of a variety of surfaceThe Children’s Hospital
antigen molecules, some of which play stage-specificBoston, Massachusetts 02115
roles in the differentiation process (Hardy et al., 1991;†Department of Pathology
for review see Rolink and Melchers, 1993).Massachusetts General Hospital
Studies of mutant mice have supported the notionHarvard Medical School
that functional expression of immunoglobulin or T cellBoston, Massachusetts 02114
receptor (TCR) genes is required to promote B and T cell‡Department of Genetics
lymphopoiesis. For example, recombination-activatingand Center for Blood Research
gene (RAG)-deficient mice lack any ability to undergoHarvard Medical School
V(D)J recombination and, correspondingly, show a com-Boston, Massachusetts 02115
plete arrest in B and T cell development at the early
stages (pro-B and pro-T, CD42CD82 cells) when this
process is normally initiated (Mombaerts et al., 1992a;Summary
Shinkai et al., 1992). Transgenic IgHC or TCRb chain
expression promotes differentiation of RAG-deficient
To test for effects on B cell differentiation, we intro-
pro-B or pro-T cells to, respectively, the pre-B and
duced immunoglobulin m heavy chain (HC) and Bcl-2 CD41CD81 stage and also leads to the accumulation of
transgenes, separately or together, into recombina- the latter cells (Mombaerts et al., 1992b; Shinkai et al.,
tion-activating gene 2 (RAG-2)-deficient mice. Trans- 1993; Spanopoulou et al., 1994; Young et al., 1994).
genic Bcl-2 expression led to increased numbers of Further differentiation of RAG-deficient precursor lym-
RAG-deficient pro-B cells, but did not promote their phocytes can be accomplished by expression of appro-
further differentiation. Expression of the m HC trans- priate IgLC or TCRa chain transgenes along with the
gene promoted the differentiation of RAG-deficient IgHC or TCRb transgenes; this promotes differentiation
pro-B cells into pre-B cells that also expressed certain of RAG-deficient lymphocytes to surface antigen recep-
differentiation markers characteristic of even more tor–expressing B or T cells, which accumulate in the
mature B cell stages. However, the extent of the m periphery (Shinkai et al., 1993; Spanopoulou et al., 1994;
HC–dependent differentiation effects was greatly en- Young et al., 1994).
hanced by coexpression of the transgenic Bcl-2 gene, Ordered rearrangement and expression of immuno-
and a subset of pre-B cells from both HC and HC, globulin genes has been suggested to direct differentia-
Bcl-2-transgenic RAG-2-deficient animals expressed tion of B-lineage cells and to provide “checkpoints” at
surface m HCs that were functional as judged by cross- which the functionality of assembled immunoglobulin
genes can be tested (Alt et al., 1986; for review seelinking experiments. These experiments demonstrate
Rajewsky, 1996). Expression of m HCs in pro-B cellsthat the pro-B to pre-B transition in vivo cannot be
regulates HC allelic exclusion and promotes the onseteffected by the expression of Bcl-2 alone, and that
of LC gene assembly (Alt et al., 1984; Reth et al., 1985;nontransformed immature B-lineage cells are compe-
Kitamura et al., 1991, 1992; Schlissel and Morrow, 1994;tent to receive signals through a surface m complex.
Young et al., 1994), in addition to providing a survival
signal requisite for further progression through theIntroduction
B-lineage pathway (Kitamura and Rajewsky, 1992; Kita-
mura et al., 1992). The m chain is thought to performB lymphocyte differentiation occurs in the bone marrow
these functions in association with the surrogate LCsof adult mice. During this process, immunoglobulin (Ig)
l5 and Vpre-B (Pillai and Baltimore, 1987; Karasuyama etheavy chain (HC) and light chain (LC) variable region
al., 1990). These complex with the Iga and Igb signaling
genes are assembled from component V, (D), and J gene
components to constitute a pre-B cell receptor (for re-
segments (reviewed by Tonegawa, 1983; Lansford et
view see Rolink and Melchers, 1993). In this context,
al., 1996). HC variable region gene assembly occurs in mutations that block membrane-bound m, l5, or Igb ex-progenitor B (pro-B) cells. Expression of m HCs pro- pression impair B cell differentiation at the pre-B stage
motes differentiation of pro-B cells to pre-B cells in (Kitamura et al., 1991, 1992; Rolink et al., 1993; Gong
which the majority of IgLC gene rearrangements occur. and Nussenzweig, 1996). Whether or not m chains or the
Functional rearrangement and expression of an IgLC pre-B receptor function on the surface of pre-B cells is
gene leads to the formation of complete immunoglobulin unknown. Surface m protein in association with surro-
molecules (HC plus LC) and the differentiation of pre-B gate LCs has been detected on a subpopulation of nor-
cells into surface IgM1 B lymphocytes (for review see mal human pre-B cells (Lassoued et al., 1993) and in
Lansford et al., 1996). Once generated, surface IgM1 murine pre-B cells in culture (Winkler et al., 1995). How-
ever, surface m chains were not readily detectable on
murine pre-B cells invivo (Cherayil and Pillai, 1991; Kara-§Present Address: Division of Hematology-Oncology, Tufts–New
England Medical Center Hospital, Boston, Massachusetts 02111. suyama et al., 1994; Spanopoulou et al., 1994; Young
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Table 1. Summary of the Percentage and Absolute Numbers of B2201 Cells in Bone Marrow and Spleen of Bcl-2 Transgenic RAG-22/2
Mice and Control Animals
Genotype Bone Marrow Spleen
Number Percent Number Number Percent Number
Mice B2201 31026 Mice B2201 31026
RAG-21/2 9 21.8 (10.4) 16.7 (6.4) 6 37.8 (9.0) 33.9 (17.7)
RAG-22/2 8 11.1 (5.0) 7.4 (3.3) 6 3.3 (3.9)  a b
0.9 (1.1)
BC RAG-22/2 7 17.9 (8.5) 12.2 (6.7) 6 11.8 (7.9) 9.6 (3.8)HC RAG-22/2 9 27.7 (7.0) 15.1 (5.3) 8 14.7 (11.2) 3.7 (2.4)
cHC BC RAG-22/2 6 37.3 (5.5) 34.7 (12.0) 9 24.8 (5.1) 20.4 (9.6)
B2201 lymphocyte populations were identified by flow cytometry as described in the legend to Figure 1 and in Experimental Procedures. All
of the samples represented here were collected from 4- to 6-week-old mice in littermate groups. The percentages of the B2201 cells in a
sample of 20,000 recorded events were determined for each mouse. Absolute numbers of lymphocytes were obtained by multiplying the total
number of cells recovered (from one femur and tibia or the spleen) by the percentage of B2201 cells in that FACS sample. The mean value
and standard deviation (in parentheses) were calculated for each group. The significance of observed variations in the number of B2201 cells
between relevant lymphoid populations (see text) in groups of mice was assessed by the Student’s t test; p values for relevant comparisons
were as follows: a, p , 0.05; b and c, p , 0.001. a, RAG-22/2 versus HC RAG-22/2; b, RAG-22/2 versus BC RAG-22/2; HC RAG-22/2 versus
HC BC RAG-22/2.
et al., 1994). Although m1 complexes on the surface of suggested that deregulated Bcl-2 expression may
achieve this differential effect by supplementing or com-murine pre-B cell lines have been shown to transduce
signals upon cross-linking (Takemori et al., 1990; Mis- plementing a function expressed earlier in the B than T
lineage, or by bypassing the requirement for surfaceener et al., 1991; Tsubata and Reth, 1992), signaling
through surface m chain complexes has yet to be dem- immunoglobulin expression during B cell ontogeny
(Strasser et al., 1994). While no role for m HC expressiononstrated in nontransformed cells.
In normal mice, the expression of functionally related in this phenomenon was considered, such a role seems
possible giventhat theV(D)J recombination defect asso-anti-apoptosis proteins such as Bcl-x and Bcl-2 show
complementary expression patterns during B cell differ- ciated with the Scid phenotype is “leaky,” allowing some
functional antigen receptor genes to be assembled (forentiation (Li et al., 1993; Fang et al., 1996; Grillot et al.,
1996). Bcl-x is more highly expressed in pre-B cells as review see Bosma and Carroll, 1991). However, it has
also been found that progenitor B cells can undergocompared with pro-B cells, and its deregulated expres-
sion leads to the expansion of a subset of pro-B cells substantial differentiation in vitro in the absence of IgHC
expression, as judged by surface antigen expressionthat have nonproductively rearranged HC genes and
which are normally targeted for cell death (Grillot et al., and IgLC transcription and rearrangement (Grawunder
et al., 1993; Melchers, 1995).1996; Fang et al., 1996). In contrast, Bcl-2 is expressed
in the earliest B-lineage-committed progenitor popula- To clarify the role of productive rearrangement and
expression of Igm HC genes in B cell differentiation andtion, is dramatically down-regulated in the pro-B and
pre-B populations, and is up-regulated again in B lym- to elucidate further the cellular and molecular events
that can effect the various transitions in B cell develop-phocytes (Li et al., 1993; Grillot et al., 1996). While Bcl-x
is necessary for normalphenotypic maturation of B cells, ment, we compared the B-lineage cell populations in
RAG-deficient mice bearing deregulated Bcl-2 trans-Bcl-2 is not (Nakayama et al., 1993; Veis et al., 1993;
Motoyama et al., 1995). However, constitutive Bcl-2 ex- genes, Igm HC transgenes, or both. These studies have
indicated that, even in the presence of deregulatedBcl-2pression expands most B-lineage populations, including
bone marrow B-lineage precursors (McDonnell et al., expression, further differentiation of pro-B cells in vivo
requires IgHC gene expression.1989; Strasser et al., 1991; Nakayama et al., 1993; Veis
et al., 1993; Smith et al., 1994), showing that Bcl-2 can
exert its anti-apoptotic functions when expressed in
early B cell developmental stages. Results
Mice homozygous for the severe combined immune
deficiency (scid) mutation (Scid mice) resemble RAG- Expression of Bcl-2 Influences Accumulation
but Not Differentiation of Pro-B Cells In Vivodeficient animals because an impaired V(D)J recombina-
tion process leads to a developmental block in lympho- To test the effect of constitutive Bcl-2 expression on
developing B-lineage cells that cannot assemble immu-poiesis at the pro-B and pro-T cell stages (for review
see Bosma and Carroll, 1991). Scid mice that express noglobulin genes, we bred mice expressing a human
Bcl-2 (BC) transgene under the control of the IgHC in-a lymphoid-specific Bcl-2 transgene were found to ac-
cumulate peripheral sIgM2 B-lineage cells that express tronic enhancer (McDonnell et al., 1989) with RAG-22/2
mice. Expression of the Bcl-2 transgene in the RAG-some surface markers associated with mature B cells;
however, these mice retained their blockage in T cell 22/2 pro-B cells was confirmed by cytoplasmic staining
with an anti-human Bcl-2 polyclonal antibody (data notdevelopment at the pro-T cell stage (Strasser et al.,
1994). On the basis of these findings, it was proposed shown). The number of B2201 (B-lineage) cells in the
bone marrow of BC, RAG-22/2 mice generally appearedthat Bcl-2 expression could promote differentiation of
Scid pro-B cells, but not Scid pro-T cells. It was further higher than that of age-matched RAG-22/2 littermates
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Figure 1. FACS Analysis of Bone Marrow and
Spleen Lymphocytes in Bcl-2 and HC186
Transgenic RAG-2-Deficient Mice and Con-
trol Animals
Cell suspensions prepared from bone mar-
row (A) or spleen (B) were surface stained
with phycoerythrin (PE)-anti-B220 and either
fluorescein (fl)-anti-CD22, biotin (bi)-anti-
IgM, or bi-anti-CD25. Biotin-labeled reagents
were detected by staining with streptavidin
(SA)–Cy-Chrome or SA–PE.Bone marrow and
spleen plots are from the same animal for
each genotype. Boxed populations (R2–R4)
in the windows displayed are B2201 subset
populations which express surface antigens
at levels appreciably above that of the
RAG2/2 or BC, RAG2/2 lymphocyte popula-
tions. For each plot, 20,000 events were col-
lected, and dead cells were excluded by size
and forward scatter gating. These assays are
representativeof resultsobtained from analy-
sis of at least five animals of the same ge-
notype.
(Table 1). However, the most striking feature of BC, RAG- markers characteristic of either thepre-B (CD21, CD251,
and syn-11) or B lymphocyte stage (IgM1, CR1/21,22/2 animals was the significantly increased number of
IgM2, B2201, CD431 (apparently pro-B stage) cells in CD221, CD231, and CD401) were evident (Figure 1).
Therefore, we conclude that constitutive Bcl-2 expres-the peripheral blood, LN, and spleen when compared
with nontransgenic RAG-22/2 animals (Figure 1; Table sion effects increased accumulation of pro-B cells in
the periphery of RAG-22/2 mice, but does not promote1; data not shown). Additional analyses of the B-lineage
cells in the bone marrow and the peripheral lymphoid the appearance of B-lineage cells that have differenti-
ated beyond the pro-B stage.compartments (spleen, LN, and peripheral blood) of BC,
RAG-22/2 mice (n 5 14) and nontransgenic controls con-
firmed that the BC, RAG-22/2 cells had a pro-B pheno- Accumulation of Novel Pre-B cells in HC,
BC, RAG-22/2 Micetype (IgM2, B220dull CD431, CD22, CD252, and syn-12;
Figures 1A and 1B; data not shown). We did observe a Expression of the m (plus d) HC186 transgene in RAG-
22/2 pro-B cells induces their differentiation to the pre-population of small, CD43dull cells in BC, RAG-22/2 mice
(data not shown), which may be analogous to that found B stage with the concomitant expression of a variety of
pre-B cell markers and the acquisition of novel growthin mice that overexpressed Bcl-x (Fang et al., 1996).
However, no B2201 cells that expressed cell surface characteristics (Era et al., 1991; Spanopoulou et al.,
Immunity
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BC Scid Peripheral Lymphocyte Populations
Another Bcl-2 transgene has been shown to promote
the appearance of peripheral lymphocytes that express
the CD21 (CR1/2), CD22, and CD23 surface markers
in the V(D)J recombination-deficient Scid background,
suggesting that Bcl-2 expression per se may promote
B cell differentiation (Strasser et al., 1994). To test
whether the transgene used in our experiments could
produce the same result, we crossed the Bcl-2
transgene into Scid mice. Consistent with the previous
observations, some (4 of 12) BC Scid transgenic mice
developed a population of B2201, sIg2, CD231CD221
CR1/21CD401 lymphocytes in peripheral lymphoid
compartments (Figure 3; data not shown); these cells
were, in fact, similar in phenotype to the peripheral B cell
populations in HC186, BC, RAG-22/2. We hypothesized
that the variability with which peripheral B-lineage cells
appeared in the BC Scid mice might be linked to their
variable success in generating functional HC genes,
consistent with the known leakiness of the Scid pheno-
type (Bosma and Carroll, 1991). To test this possibility,
we assayed purified B2201CD221 splenocytes from BC
Figure 2. Surface Expression of Mature B Cell Antigens CD23 and Scid (Figures 4A and 4B), HC186 RAG-22/2 (Figures 4C
CR1/2 on HC186, BC, RAG-22/2–Derived Splenocytes and 4D), and HC186, lLC RAG-22/2 (which have B220hi,
Splenocytes from age-matched RAG-21/2, HC186, RAG-22/2 and sIg1 peripheral Bcells; Figure 4E) mice for cytoplasmic m
HC186, BC, RAG-22/2 mice were stained with fl-anti-B220 and PE- protein by an indirect immunofluorescence assay. While
anti-CD23 or PE-anti-B220 and bi-anti-CR1/2. Biotin staining of
there were variations in intensity, cytoplasmic m expres-splenocytes was detected with SA–Cy-Chrome staining.
sion was evident in the majority of cells in all three
populations (Figure 4). These results indicate that the
1994; Young et al., 1994). To elucidate further potential peripheral B-lineage cells observed in BC, Scid mice,
effects of HC gene expression on B cell differentiation like those in HC186, BC, RAG-22/2 mice, derive from
and homing, we analyzed secondary lymphoid tissues
pre-B cells that have functionally assembled IgHC
in HC186, RAG-22/2mice. These animals consistently
genes. By the staining procedure used, we cannot dis-
had more B2201 cells in the spleen, LN, and peripheral
tinguish whether these functional rearrangements in BC,
blood compared with RAG-22/2 littermates, suggesting
Scid mice resulted in either partial (Dm; Reth and Alt,that HC1 pre-B cells can more efficiently colonize pe-
1984) or complete m HC protein expression.ripheral tissues than HC2 pro-B cells (Table 1; Figure 1;
data not shown). Moreover, we also detected a popula-
tion of B2201 cells in both bone marrow and peripheral HC186, BC, RAG-22/2–Derived Lymphocytes
lymphoid tissues from HC186 RAG-22/2 mice that ex-
Establish Lymphoid Bone Marrow Cultures
pressed detectable surface levels of markers associated
and Transcribe Pre-B Cell–Specific Geneswith more mature B cell differentiation stages, incuding
Although mature B cell surface antigen markers wereCD22 (Figures 1A and 1B) and CD40 (Castigli et al.,
detected on HC186, BC, RAG-22/2 lymphocytes, these1996), but not IgM (Figure 1).
cells also expressed CD25 and syn-1; the latter markersTo test whether HC expression may promote genera-
first appear at the pre-B cell stage of development (Fig-tion of further differentiated cells with limited survival
ure 1; data not shown), are generally absent from thepotential, we introduced the Bcl-2 transgene into the
surface of mature circulating B lymphocytes (IgM1IgD1),HC186, RAG-22/2 background to generate HC186, BC,
and reappear at high levels on the surface of activatedRAG-22/2 mice. All HC186, BC, RAG-22/2 animals had
B lymphocytes and plasma cells (Figures 1A, 1B, and 2;significantly increased numbers of B2201 cells in periph-
Sanderson et al., 1989; Nakanishi et al., 1992). Activatederal lymphoid organs compared with age-matched
mature B cells normally do not expand under lymphoidHC186 RAG-22/2 animals (Table 1; data not shown).
bone marrow culture conditions and do not expressHC186, BC, RAG-22/2–derived peripheral B-lineage
mRNA from precursor B cell–specific genes such as l5cells also had consistently higher surface levels of CD22
and RAG-1 (Rolink and Melchers, 1993; F. Y. andand CD40 compared with HC186 RAG-22/2 littermate
F. W. A., unpublished data). To determine whethercontrols (Figure 1). In addition, the HC186, BC, RAG-
B-lineage cells from HC186, BC, RAG-22/2 mice retain22/2–derived cells also expressed surface CD23 and
features characteristic of normal bone marrow B cellCR1/2 (Figures 1 and 2) and appeared to have low levels
precursors, we attempted to establish IL-7-supple-of surface m expression (Figure 1; see below). In general,
mented lymphoid cultures and to measure the steady-the expression levels of all “mature” cell surface antigen
state levels of transcripts from various pre-B cell–markers tested were lower on HC186, BC, RAG-22/2
specific genes by Northern blot analysis. We found thatperipheral B-lineage cells than on mature B cells derived
lymphoid cultures were readily established from eitherfrom RAG-21/2 littermates (Figures 1 and 2; data not
shown). bone marrow or spleen cells derived from HC186, BC,
Role of Igm HCs in Precursor B Cell Differentiation
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Figure 3. FACS Profile of Splenocytes from
scid and Bcl-2 Transgenic Scid Mice
Cell suspensions prepared from the spleens
of a BC Scid and a Scid littermate were
stained with PE-anti-B220, bi-anti-CD25, and
fl-anti-CD22. The BC Scid mouse repre-
sented here had the most significant popula-
tion of peripheral lymphocytes detected in
the BC Scid colony, with 8.2% B2201 cells in
R4 and 10.1% in R5, based on 20,000 events
collected within a “lymphocyte gate” defined
by forward and side scatter characteristics. Among genotypically defined BC Scid mice, 8 of 12 did not develop CD221/CD251 populations;
these animals were indistinguishable by FACS from nontransgenic Scid littermates.
RAG-22/2 mice (9 of 9 attempts with bone marrow and HC186, BC, RAG-22/2 Lymphocytes Can
Signal through Surface m7 of 9 atttempts with spleen cells). As expected, control
In agreement with previous studies, we did not detectcultures seeded from RAG-21/2 spleen did not grow,
any m protein on the surface of HC186, RAG-22/2and bone marrow–derived cultures had a predominantly
B-lineage cells (Karasuyama et al., 1994; Spanopouloupro-B cell phenotype (data not shown). In contrast, cells
et al., 1994; Young et al., 1994). However, staining offrom both bone marrow and spleen HC186, BC, RAG-
HC186, BC, RAG-22/2 spleen, bone marrow, and periph-22/2–derived lymphoid cultures expressed surface
eral blood with monoclonal anti-m-specific antibodiesCD22, CD21 (CR1/2), CD23, and CD40 (Figure 5A; data
suggested the presence of low levels of HC protein onnot shown; Castigli et al., 1996). Furthermore, Northern
the surface of some B2201 lymphocytes (Figure 1; datablot analysis of RNA from these spleen cultures revealed
not shown). CD69, a cell surface marker that is up-
steady-state transcripts of the pre-B-specific l5 and regulated as early as 3 hr after engagement of immuno-
RAG-1 genes (two separate experiments are shown in globulin or TCR receptors, has been useful in activation
Figure 5B; HC186 RAG-22/2–derived pre-B cell RNA was studies of immature lymphoid cells, which are suscepti-
used as a control in these experiments). These findings ble to cell death following cross-linking (Swat et al.,
suggest that the bone marrow and periphery of HC186, 1993). Following an 8–12 hr incubation with the multiva-
BC, RAG-22/2 has a major population of phenotypically lent cross-linking agent anti-IgMa–dextran (Brunswick
novel B-lineage cells that coexpress pre-B markers to- et al., 1989; Pecanha et al., 1991), we detected up-regu-
gether with certain markers previously associated only lation of CD69 and CD23 on the surface of B2201 lym-
phocytes derived from HC186, BC, RAG-22/2 spleen orwith mature B-lineage cells in normal mice.
Figure 4. B2201CD221 Splenocytes from BC
Scid Mice Express m HC Protein in the Cyto-
plasm
Splenocytes from two BC Scid mice (A and
B) and a HC186, lLC RAG-22/2 mouse ([E]
and data not shown) were stained with anti-
B220-Cy-Chrome and fl-anti-CD22; cyto-
preps of sorted double positive cells were
subsequently stained with goat anti-m or goat
anti-k (data not shown), followed by Cy-3-
conjugated donkey anti–goat IgG. Spleno-
cytes from HC186 RAG-22/2 mice (C and D)
were processed identically except that fl-
anti-CD2 was used in place of anti-CD22.
Photographs were taken through a 403 ob-
jective on an Olympus BX60 camera with ASA
800 film and using narrow band-pass filters.
(E) was photographed at one-twelfth the
shutter speed of (A)–(D).
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Figure 6. Up-Regulation of Surface CD69 following Anti-m Stimula-
tionof Splenocytes from HC186,BC, RAG-22/2 andHC186 RAG-22/2
Mice
Splenocytes from a Balb/c (IgHa) mouse and from HC186 (IgHa)
transgenic, RAG-22/2, and BC, RAG-22/2 mice were incubated with
anti-IgMb–dextran (top) or anti-IgMa–dextran (middle) and then
stained with fl-anti-B220 and bi-anti-CD69 followed by SA–PE. The
histograms displayed represent B2201 cells. An overlay of the top
and middle panels is presented at the bottom. These data were
reproduced in three separate experiments.
Figure 5. Lymphoid Cultures Established from HC186, BC,
alone. These data demonstrate that cross-linking of sur-RAG-22/2 Splenocytes Express B Cell Precursor Genes
face m on in vivo derived pre-B cells transduces a signal(A) Lymphoid culture cells established from HC186 RAG-22/2 bone
marrow or HC, BC, RAG-22/2 spleen were stained with PE-anti- across the cell membrane.
B220 and bi-anti-CR1/CR2. Binding of biotinylated antibodies was
detecteded by SA–Cy-Chrome staining. HC186, BC, RAG-22/2 Mice Develop Defined
(B) Steady-state transcripts of the pre-B cell–specific genes RAG-1
Lymphoid Follicles in the Spleen(6.0 kb), and l5 (1.2 kb) were detected by the serial hybridization of
B lymphocyte homing to specific splenic microenviron-specific probes to Northern blots containing 12 mg of total RNA
ments is mediated by intercellular adhesion moleculesfrom bone marrow– or spleen-derived lymphoid cultures. mb-1 (1.0
kb) hybridization signals were used in these experiments as a rela- (for review see Picker and Siegelman, 1993). Mature B
tive measure of the number of B-lineage cells in each sample. The cells arriving in the spleen generally migrate to lymphoid
cultures depicted in (A) are represented in lanes 1 (bone marrow– follicles, which are anatomically distinct from the
derived HC186 RAG-22/2 as a positive control for pre-B cells) and
“T-dependent” areas immediately adjacent to arterioles2 (spleen-derived HC186, BC, RAG-22/2) of (B). Lanes 3–5 in (B)
(Parrott et al., 1966). To examine the organization ofrepresent similar cultures obtained in a separate experiment.
B-lineage populations in peripheral lymphoid organs,
we performed immunohistochemical analyses of B2201
cells in frozen sections from normal (Figure 7A), RAG-bone marrow (Figure 6; data not shown). As a specificity
control, we used anti-IgMb–dextran antibodies and me- 22/2 (Figure 7B), BC, RAG-22/2 (Figure 7C), HC186, RAG-
22/2 (Figure 7D), and HC186, BC, RAG-22/2 mice (Figuredia supplemented with dextran alone. Using culture con-
ditions optimized to reveal CD69 up-regulation on 7E). Although B2201 cells were visualized in each of the
animals examined (two of each genotype), recognizableHC186, BC, RAG-22/2 lymphocytes (see legendto Figure
6 and Experimental Procedures), we also detected up- lymphoid follicles distinct from the periarteriolar
T-dependent areas of the spleen were visible only inregulation of CD69 on a fraction of HC186 RAG-22/2
pre-B cells stimulated with anti-IgMa–dextran (Figure 6; the normal and in the HC186, BC, RAG-22/2–derived
lymphoid tissues. Staining of HC186, BC, RAG-IgHa-expressing splenocytes from Balb/c mice were
used as a control for antibody specificity). Parallel cul- 22/2–derivedspleen sections with anti-m antibodiescon-
firmed that the cells in these lymphoid follicles weretures incubated with anti-IgMb–dextran showed no
change in CD69 expression compared with dextran cytoplasmic m1 (data not shown). These data show that,
Role of Igm HCs in Precursor B Cell Differentiation
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Figure 7. Follicular Localization of B-Lineage
Cells in HC186, BC, RAG-22/2 Spleen
Spleen sections from normal (A), RAG-22/2
(B), BC, RAG-22/2 (C), HC186 RAG-22/2 (D),
and HC186, BC, RAG-22/2 (E) mice were
stained with rat anti-B220 and revealed by
indirect immunohistochemical staining. The
slide was counterstained with hematoxylin.
Photographs were taken through a 253 ob-
jective.
after leaving the bone marrow, HC186, BC, RAG-22/2 cell populations of RAG-2-deficient mice. While BC,
RAG-22/2 animals had increased numbers of B-lineagelymphocytes can disperse into specialized microenvi-
ronmental domains even in the absence of LC re- cells in bone marrow and peripheral lymphoid organs
compared with RAG-22/2 animals, the phenotype of allarrangement.
BC, RAG-22/2 B-lineage cells clearly remained that of
pro-B cells. The lack of differentiative effects was notDiscussion
due to the RAG2/2 genotype, because similar results
were obtained in BC, JH2/2 mice, which had normalIgm HC, but Not Bcl-2 Expression, Promotes
Differentiation of Pro-B Cells In Vivo RAG alleles and contained normal populations of T cells
(J. Chen, F. Y., and F. W. A., unpublished data). WeExpression of a m HC transgene in the RAG-deficient
background has been shown to promote the phenotypic conclude that, in the context of the bone marrow micro-
environment, blocking apoptotic cell death by constitu-transition of RAG-deficient pro-B cells into pre-B cells
(Young et al., 1994; Spanopoulou et al., 1994). We now tive expression of Bcl-2 leads to an increase in the num-
ber of pro-B cells, but does not effect differentiation ofshow that such expression also leads to the accumula-
tion of a subset of pre-B cells that express certain differ- pro-B cells to the pre-B stage or beyond.
Our studies indicate that, even in the context of dereg-entiation markers (i.e., CD22 and CD40) previously asso-
ciated with more mature B cell stages and leads to the ulated Bcl-2 expression, m chain expression is required
to promote maturation of pro-B cells in vivo. However,appearance of significant numbers of these “mature”
pre-B cells in the periphery. Previous studies of Scid in the RAG2/2 background, the extent of the m HC–
dependent differentiation effects was greatly enhancedmice harboring a different Bcl-2 transgene led to the
suggestion that expression of Bcl-2 can similarly pro- by coexpression of transgenic Bcl-2. Compared with
HC, RAG-22/2 mice, BC, HC, RAG-22/2 mice had anmote the differentiation of Scid B-lineage cells (Strasser
et al., 1994). To clarify this issue, we have tested whether even greater number of peripheral B-lineage cells; the
BC, HC, RAG-22/2 peripheral pre-B cells also bore addi-further differentiation of pre-B cells is dissociable from
immunoglobulin protein expression in vivo by assaying tional surface markers of more differentiated B cells and
exhibited microenvironmental homing. Furthermore, inthe effect of deregulated Bcl-2 expression on the pro-B
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BC, Scid mice, we found that many such “differentiated” survival of HC, BC, RAG-22/2 B-lineage cells may allow
accumulation of higher levels of surface m chains. Alter-peripheral B-lineage cells expressed cytoplasmic m HC
proteins; these cells, therefore, likely represent m-posi- natively, it is possible that m chains are more highly
expressed on the surface of a transitional, short-livedtive Scid pre-B cells that were generated as a result
of leaky Scid V(D)J rearrangements and expanded by adult bone marrow–derived pre-B cell population that
is expanded in the presence of the Bcl-2 transgene.transgenic Bcl-2 expression. This finding may also ex-
plain the similar occurrence of this phenomenon in the If so, the expression of the additional mature surface
markers and enhanced ability to migrate to appropriateseparate line of Bcl-2 transgenic, Scid mice analyzed
by others (Strasser et al., 1994). Conceivably, cells of peripheral lymphoid compartments may also be ac-
quired at this stage. In this regard, the coexpression ofthis novel phenotype are generated in normal mice via
m chain expression, but in the absence of LC expression normally asynchronous differentiation markers is also
a distinguishing feature of human acute lymphoblasticare too short-lived to accumulate to detectable levels
(see below). In contrast with our in vivo findings, analy- leukemia (ALL) cells, which are cm1 and have been ob-
served to express abnormally high levels of Bcl-2 proteinses of the in vitro differentiation of precursor B cell lines
derived from normal, mutant, and Bcl-2 transgenic mice (Campana et al., 1993; for review see Hunger, 1996), as
well as for B-lineage tumors which arise in Em–myc micehas suggested that pro-B cells can undergo significant
further differentiation (to the pre-B stage or beyond) in and which have a combination of pre-B and B cell char-
acteristics (Ma et al., 1992). While the transformationthe absence of productive immunoglobulin gene re-
arrangements (Grawunder et al., 1993; Melchers, 1995). process itself may result in alterations in normal surface
antigen expression patterns, our current findings areTaken together with our results, the latter observations
may imply that there are additional constraints on the consistent with the hypothesis that malignancies such
as ALL may involve “transitional” bone marrow cellsaccumulation of more differentiated cells in vivo as com-
pared with in vitro and that, in vivo, these constraints coexpressing markers traditionally assigned to different
developmental stages (Greaves, 1986, 1993).are relieved by the expression of IgHC proteins.
Many aspects of the developmental programs of B
and T lymphocytes are similar (for reviews see Chen
Pre-B Cells May Express Functional m HCand Alt, 1993; Borst et al., 1996). However, enforced
Proteins on Their Surfaceexpression of Bcl-2 appeared to affect pro-B versus
The question of whether the m chain (pre-B receptor)pro-T populations differentially (McDonnell et al., 1989;
must be expressed on the cell surface to function hasStrasser et al., 1991, 1994), as no expansion or increased
not been resolved (see Borst et al., 1996). In this regard,survival in vitro of BC Scid thymocytes or appearance
surface m was not detected on pre-B cells freshly iso-of differentiated T-lineage cells was found in a BC Scid
lated from adult mice (Karasuyama et al., 1994; Spano-mouse line that expressed Bcl-2 inT-lineage cells (Stras-
poulou et al., 1994; Young et al., 1994), but has beenser et al., 1994). The “negative” results in the BC Scid
detected on murine pre-B cells cultured at 378C (WinklerT lineage as compared with B-lineage cells led to the
et al., 1995) and by the ability of anti-m antibodies tosuggestion that the anti-apoptotic effects of Bcl-2 might
synergize with suboptimal concentrations of CD19 independ on the presence of factors that are differentially
calcium mobilization experiments (Krop et al., 1996).expressed at the pro-B but not pro-T cell differentiation
Surface m was also found on transformed pre-B cellstages. However, more recent analyses of Bcl-2, RAG-
lines (Pillai and Baltimore, 1987; Takemori et al., 1990;12/2 mice (in which Bcl-2 expression was specifically
Cherayil and Pillai, 1991; Misener et al., 1991). Moreover,directed to the T lineage), found a modest increase in
a fraction of human fetal bone marrow pre-B cells, ap-thymocyte numbers and the appearance of a small num-
parently of a relatively mature phenotype (CD342,ber of double positive cells (Linette et al., 1994). In light
CD201), expressed surface m at low levels (Lassoued etof the evidence presented in our studies delineating the
al., 1993; reviewed by Burrows et al., 1995). Of potentialrole of IgHC production in the appearance of differenti-
significance, we also found that the HC186, BC, RAG-ated Bcl-2 transgenic Scid and RAG2/2 peripheral B
22/2 and HC186 RAG-22/2 murine pre-B cell populationscells, it will be important to compare the survival and
that express surface m tend to express more matureexpansion properties of T-lineage cell populations that
surface markers. The notion that surface m chains onarise in Scid and RAG-deficient mice that harbor TCRb
pre-B cells performdevelopmentally important signalingor Bcl-2 transgenes, or both.
functions has been most strongly supported by the B
cell developmental arrest and the loss of HC allelic ex-
clusion in mice unable to express the membrane-boundThe Nature of HC, BC, RAG-22/2 Pre-B Cells
The novel B-lineage cells that expand in HC186, BC, form of the m chain (Kitamura et al., 1992). These and
additional gene targeted mutational studies have im-RAG-22/2 mice likely represent a population of cells that
have completed the pre-B differentiation program, but plied that the m chain may perform these functions in
the context of the pre-B cell receptor (Kitamura et al.,are blocked at the pre-B/B cell junction owing to an
inability to undergo IgLC rearrangements and which are 1992; Rolink et al., 1993). In this regard, our current
studies demonstrate that surface m chains on pre-B-accumulated by the enforced Bcl-2 expression. It is
striking that pre-B lymphocytes freshly isolated from stage cells isolated from the bone marrow are, in fact,
coupled to cellular signaling pathways. While these ob-HC, BC, RAG-22/2 mice express readily detectable lev-
els of surface m, while those harvested from HC186, servations were made on m HC transgenic pre-B cells
from RAG-22/2 mice, they strongly argue that, most likelyRAG-22/2 mice do not. It is possible that prolonged
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room temperature, and then transferred to 2708C until use. Forat a later pre-B stage, normal immature B-lineage cells
staining, cytospots were fixed and permeabilized by immersion ofmay be competent to receive signals through a surface
the slide in ice-cold acetone (08C) for 15 s, followed by ice-coldm complex.
methanol (08C) for 1.5 min, and then placed in cold PBS (48C) for
5 min. Cytospots were then incubated at room temperature in a
Experimental Procedures humidified chamber with 0.040 ml of goat anti-m (Jackson Immuno-
chemicals) or goat anti-k (Southern Biotechnology) antibodies (di-
Flow Cytometry Analysis luted to 10 mg/ml in PBS, 0.5% fetal calf serum) for 4 hr. Slides were
FACS analysis of single cell suspensions from bone marrow, spleen, then washed three times by immersion in PBS and then incubated
lymphnode (LN), andperipheral blood were carried out as previously for 2–4 hr at 48C or 4–8 hr at room temperature with Cy-3-conjugated
described (Parks et al., 1986) with the following modification: non- donkey anti–goat IgG (Jackson Immunochemicals). We consistently
specific staining of splenocytes and LN-derived cells was found to found that BC Scid lymphocytes were more sensitive to manipula-
be significantly reduced if cell suspensions were incubated in 50% tion than HC186 RAG-22/2 pre-B cells and that significant decreases
heat-inactivated normal rat serum (Zymed Labs, South San Fran- in intact cell numbers occurred after cytospin and fixation. Tissue
cisco, CA) for 10 min prior to staining with antibodies specific for samples from spleen and mesenteric LN were harvested, immersed
cell surface antigens. Reactivity of specific antibodies with cells in in OCT compound (Ames, Elkhart, IN), frozen on dry ice, and stored
the lymphocyte gate were analyzed on FACScan (Becton Dickinson, at 2808C. Frozen tissue sections (4 mm thick) were air dried for 2
Mountain View, CA) with LYSYS software. The anti-CR1/2 antibody hr, fixed in ice-cold acetone for 7 min, air dried again, and then
was a gift of T. Kinoshita (Osaka University, Japan). endogenous peroxidase activity was blocked and the sections were
stained by the avidin–biotin complex method as described pre-
Mice viously (Mombaerts et al., 1993). Antibodies used wereCD45R/B220,
All mice used in this experiment were bred and maintained at Chil- purified RA3-6B2, and anti-Igm-purified R6-60.2 (Pharmingen) at
dren’s Hospital, Boston. The mice containing the human Bcl-2 1:20, followed by biotinylated rabbit anti–rat IgG (Vector) at 1:100
transgene were a gift of S. Korsmeyer, St. Louis, MO (McDonnell et and SA–HRP.
al., 1989). CB.17 Scid mice were purchased from Charles River
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